Mad Money W/ Jim Cramer

With the stock up nearly 18% in the last week, Jim Cramer’s checking in with the high-flying RingCentral to make sense of the recent action. Then, Ollie’s stock has been beaten down as of late, so is it finally a bargain at these levels? Cramer’s digging into the company and seeing if now is the time to buy. Plus, Cramer’s turning in his homework on Cardlytics to see if the stock up nearly 440% in the last year has more room to run. 

Shopify surged nearly 8% today after strong earnings, and Jim Cramer’s going one-on-one with the company’s COO to make sense of the quarter and the company’s plans for the future. Then, Signet, the company behind Kay Jewelers and Piercing Pagoda, is up over 150% from its September 2019 lows, and Cramer’s going on the record with the company’s CEO to talk holiday sales and the turnaround in the stock. Plus, analysts are mixed regarding the future of Canada Goose, and Cramer’s sharing whether he believes a turnaround story is in the cards for the high-end parka manufacturer.  

Columbia Sportswear’s stock is down from its highs, but does that create a buying opportunity? Cramer’s checking in with the company’s CEO. Then, with the stock up nearly 10% today, Cramer’s talking with the CEO of Charles River Labs to make sense of the quarter for the company that aids in the drug development process. Plus, Cramer’s going Off The Charts to get a read on the market and see if record highs can continue to be in our future. 

After reporting earnings last week, Take-Two Interactive’s stock got hit, but could this be a buying opportunity? Jim Cramer’s checking in with the company’s CEO to make sense of the quarter. Then, Uber’s stock has cruised higher lately, but could the performance continue? Cramer’s giving his take on the stock. Plus, Cramer’s revealing one of the reasons why he believes oil and gas stocks are bad long-term investments. 

CNBC's Mad Money with Jim Cramer.

In the midst of an election year the insurance companies are in focus, and tonight, Cramer’s checking in with one of the biggest players out there, Cigna, to see what’s on the horizon for the company. Then, McCormick’s stock got grilled after reporting earnings last week, so what should you make of the stock here? Cramer’s checking in with the CEO of the seasoning kingpin. Plus what should you make of Elliott Management’s plan for Evergy? Cramer’s giving his take on the stock. 

Amid the Coronavirus, Cramer’s checking in with Clorox to learn more about the impact on the company’s bottom line and what’s on the horizon. Then, Boot Barn was down nearly 10% after reporting earnings, but could the declines present a buying opportunity? Cramer’s talking to the company’s CEO. Plus, the CEO of Teladoc joins Cramer to discuss the future of telemedicine and what the company is seeing this flu season. 

CNBC's Mad Money with Jim Cramer.

With Zoom Video’s stock up 15% today, Jim Cramer’s sitting down with the company’s CEO to learn more about what caused the bump in the stock and what he sees on the horizon for the company. Then, after one of the biggest nights in television and sports, Cramer’s digging into the streaming wars and giving the name of a player that should be on your radar. Plus, in the midst of the coronavirus, Cramer’s got the CEO of Doctor on Demand to discuss what the company has seen so far this flu season and his take on the coronavirus outbreak. 

CNBC's Mad Money with Jim Cramer.

CNBC's Mad Money with Jim Cramer.

This morning, Penn National Gaming announced a 36% stake in Barstool Sports and the stock surged nearly 11%. Tonight, Jim Cramer’s getting details of the deal with Penn National’s CEO, and Barstool Sports’ CEO, and Founder. Then, after reporting earnings last night, could Stryker’s post-earnings decline be a buying opportunity? Cramer’s digging into the report with the CEO. And Cramer’s giving his take on two hot stocks— Roku and Shopify. 

It was a big day for earnings, and Jim Cramer’s making sense of Apple’s report. Then, this week all eyes are on football, but what about basketball and hockey? Cramer’s digging into The Madison Square Garden Company and its upcoming spinoff of its entertainment assets and sports teams. Plus, Epic System’s CEO just sent an email urging hospital CEOs to keep patients data private, and tonight Masimo’s CEO is responding with his feelings on the benefits of open data in the healthcare space.  

CNBC's Mad Money with Jim Cramer.

With the Coronavirus weighing on today’s averages, Jim Cramer’s giving you his Game Plan and sharing what should be on your radar for next week. Then, L Brands has recently caught 4 upgrades from analysts, but could the stock be a good fit for your portfolio? Cramer’s giving you his take on the owner of Victoria Secret and Bath & Body Works. Plus, Cramer’s finishing up the week with a round of “Am I Diversified’.

With rumors swirling regarding a buyout, Jim Cramer is sitting down with Grubhub’s CEO from Art Bird in Grand Central Station to make sense of the headlines. Then, at the end of 2019 First Horizon announced it was acquiring Iberiabank, and tonight Cramer’s making sense of the deal and what it means for the year ahead. And what should you make of Snap’s recent picture perfect performance? Cramer’s digging into the stock’s history and seeing if it has more room to run. 

Jim Cramer’s got his eye on energy and is checking in with one of his favorite oil and gas analysts, RBN Energy’s Rusty Braziel. Then, the headlines are focused on the coronavirus, and Cramer’s taking apart what stocks could be directly hit from the virus versus others that could just be collateral damage. Plus, Cramer’s going ‘Off The Charts’ on three medical device makers to see if this could be a space worth looking into.  

Before leaving the west coast, Jim Cramer stopped at Costco’s flagship store in Washington State to sit down with the company’s CEO to learn more about the company’s recipe for success. Then, after catching a few downgrades in the beginning of 2020, what should you make of Logitech’s top and bottom line beat? Cramer’s got the exclusive with the company’s CEO. Plus, the market has taken a bite out of United Natural Foods, so how should you digest the performance? Cramer’s giving his take on the company. 

CNBC's Mad Money with Jim Cramer.

After hitting an all time high today, Cramer’s heading out west to Redmond, Washington, where he’s sitting down with Microsoft’s CEO and CFO after the company announced its plan to be better than carbon neutral by 2030. And, last night before leaving San Francisco, Cramer spoke with GW Pharmaceuticals CEO to learn more about the company’s 4Q ‘19 pre-announcement and the success of its cannabis-based drug, Epidiolex.